Drug Shortage Report for SOLYSTAT

Last updated on 2024-10-16 History
Report ID 234061
Drug Identification Number 00755338
Brand name SOLYSTAT
Common or Proper name Solystat
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) SODIUM POLYSTYRENE SULFONATE
Strength(s) 1G
Dosage form(s) POWDER FOR SUSPENSION POWDER
Route of administration RECTAL ORAL RECTAL ORAL
Packaging size 454g
ATC code V03AE
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2024-07-30
Actual start date
Estimated end date 2024-10-15
Actual end date 2024-10-15
Shortage status Resolved
Updated date 2024-10-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-10-16 English Compare
v9 2024-10-15 French Compare
v8 2024-10-15 English Compare
v7 2024-10-11 French Compare
v6 2024-10-11 English Compare
v5 2024-09-03 French Compare
v4 2024-09-03 English Compare
v3 2024-07-31 English Compare
v2 2024-07-30 French Compare
v1 2024-07-30 English Compare

Showing 1 to 10 of 10